MarketWatch

Next Generation Sequencing (NGS) Market Poised to Hit $42.25 Billion by 2033: Key Drivers Behind the Surge - Latest Study by Grand View Research, Inc.

SAN FRANCISCO, Nov. 13, 2025 /PRNewswire/ -- The global next-generation sequencing market size is anticipated to reach USD 42.25 billion by 2033, growing at a CAGR of 18.0% from 2025 to 2033. The next ...

Global Next-Generation Sequencing (NGS) Market to Double in Size by 2030 - Asia-Pacific NGS Market Poised for Fastest Growth, Driven by Large-Scale Genomic Projects and the ...

Generation Sequencing Market by Product Type, Technology, Workflow, Services, Application - Global Forecast to 2030" has been added to ResearchAndMarkets.com's offering. The next-generation sequencing ...
Business Wire

Velsera and Sentieon’s Pangenotyper Wins Bio-IT World 2024 Best-of-Show

BOSTON--(BUSINESS WIRE)--Velsera and Sentieon are pleased to announce their joint receipt of the Best-of-Show award at Bio-IT World 2024 for their innovative NGS secondary analysis solution, ...
EurekAlert!

First joint overview of PCR deduplication and error correction revolutionizes NGS data analysis

A landmark study, titled “How error correction affects polymerase chain reaction deduplication: A survey based on unique molecular identifier datasets of short ...
Seeking Alpha

Bionano Announces Upgrades to its Software and Compute Platforms to Make Analysis of OGM, Microarray and NGS Data Easier, Faster and More Accurate

SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today announced the release of the latest versions of its VIA™ and Solve™ software for genomic data analysis and upgrades to ...
Business Wire

NuGEN Webinar Features New Sample Prep Method for NGS Analysis of Multiple Changes in 500+ Cancer Gene Targets

SAN CARLOS, Calif.--(BUSINESS WIRE)--NuGEN Technologies is pleased to present a Webinar featuring the company’s newly launched Ovation Cancer Panel 2.0 Target Enrichment System--a sample preparation ...
ascopubs.org

NGS-based molecular panel analysis of metastatic prostate cancer for daily routine: How often do we detect druggable mutations?

Assessment of PARP1 mRNA expression as prognostic of aggressive pathology and adverse outcomes, and as predictor of response to PARP inhibition in castration-sensitive prostate cancer. Association of ...